/Bio-Techne%20Corp%20sign-by%20JHVEPhoto%20via%20Shutterstock.jpg)
Bio-Techne Corporation (TECH), with a market cap of $12.3 billion, is a global biotech company that develops, manufactures, and sells biotechnology products and clinical diagnostic controls, headquartered in Minneapolis, Minnesota. It is expected to announce its Q4 earnings, before the market opens on Wednesday, Aug. 7.
Ahead of the event, analysts expect Bio-Techne to report a profit of $0.44 per share, down 21.4% from $0.56 per share reported in the year-ago quarter. The company has surpassed Wall Street’s EPS estimates in two of the past four quarters while missing on two other occasions. It reported an EPS of $0.44 in the latest quarter, beating the consensus estimate by 10%.